Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 IL17F 1件: Th17 cell differentiation D11550 Bimekizumab 3件: 46, 97, 271
2 MAPK14 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
3 MAPK14 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
4 MTOR 4件: Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D00753 Sirolimus 41件: 2, 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331
5 MTOR 4件: Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D02714 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277
6 MTOR 4件: Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus D06068 Temsirolimus 4件: 13, 34, 89, 331
7 HLA-DMA 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
8 HLA-DMB 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
9 HLA-DOA 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
10 HLA-DOB 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
11 HLA-DPA1 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
12 HLA-DPB1 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
13 HLA-DQA1 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
14 HLA-DQA2 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
15 HLA-DQB1 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
16 HLA-DRA 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
17 HLA-DRB1 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
18 HLA-DRB3 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
19 HLA-DRB4 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
20 HLA-DRB5 5件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Viral myocarditis D04318 Glatiramer 4件: 2, 13, 96, 156
21 IFNG 4件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D04242 Fontolizumab 1件: 46
22 IFNG 4件: Th17 cell differentiation, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis D11120 Emapalumab 2件: 49, 107
23 IFNGR1 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
24 IFNGR2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
25 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
26 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D06635 Rilonacept 4件: 51, 106, 107, 266
27 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09315 Canakinumab 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269
28 IL1B 6件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Yersinia infection, Tuberculosis D09911 Gevokizumab 4件: 41, 50, 56, 269
29 IL1R1 1件: Th17 cell differentiation D02934 Anakinra 19件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299
30 IL2RA 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
31 IL2RA 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03058 Basiliximab 6件: 2, 50, 66, 97, 222, 228
32 IL2RA 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D03639 Daclizumab 8件: 13, 56, 60, 65, 97, 107, 283, 284
33 IL2RB 3件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation, Transcriptional misregulation in cancer D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
34 IL2RG 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
35 IL4 1件: Th17 cell differentiation D03117 Binetrakin 1件: 46
36 IL4R 1件: Th17 cell differentiation D10354 Dupilumab 4件: 51, 98, 160, 162
37 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
38 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D08976 Pomalidomide 6件: 28, 34, 51, 85, 227, 331
39 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D09669 Siltuximab 2件: 28, 331
40 IL6 7件: Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer D10080 Sirukumab 2件: 41, 46
41 IL6R 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D02596 Tocilizumab 21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
42 IL6R 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D10161 Sarilumab 5件: 41, 46, 84, 107, 271
43 IL6R 2件: Viral protein interaction with cytokine and cytokine receptor, Th17 cell differentiation D11079 Satralizumab 2件: 11, 13
44 IL17A 1件: Th17 cell differentiation D09967 Secukinumab 8件: 13, 37, 41, 46, 107, 160, 269, 271
45 IL17A 1件: Th17 cell differentiation D10071 Ixekizumab 6件: 36, 37, 107, 162, 269, 271
46 IL17A 1件: Th17 cell differentiation D11127 Tibulizumab 1件: 53
47 IL17A 1件: Th17 cell differentiation D11550 Bimekizumab 3件: 46, 97, 271
48 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09959 Ruxolitinib 1件: 228
49 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
50 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
51 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10653 Peficitinib 1件: 46
52 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
53 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10944 Itacitinib 5件: 46, 51, 60, 97, 228
54 JAK1 4件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
55 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09959 Ruxolitinib 1件: 228
56 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
57 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10308 Baricitinib 13件: 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
58 JAK2 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D10653 Peficitinib 1件: 46
59 JAK3 2件: Th17 cell differentiation, Viral carcinogenesis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
60 JAK3 2件: Th17 cell differentiation, Viral carcinogenesis D10653 Peficitinib 1件: 46
61 LCK 2件: Th17 cell differentiation, Yersinia infection D03658 Dasatinib 2件: 51, 85
62 LCK 2件: Th17 cell differentiation, Yersinia infection D06414 Dasatinib 2件: 51, 85
63 NFKB1 8件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D01146 Iguratimod 4件: 46, 51, 53, 271
64 IL22 1件: Th17 cell differentiation D11953 Efmarodocokin alfa 2件: 96, 97
65 IL23A 2件: Th17 cell differentiation, Tuberculosis D09214 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
66 IL23A 2件: Th17 cell differentiation, Tuberculosis D10400 Tildrakizumab 2件: 162, 271
67 IL23A 2件: Th17 cell differentiation, Tuberculosis D10438 Guselkumab 5件: 37, 41, 51, 96, 97
68 IL23A 2件: Th17 cell differentiation, Tuberculosis D10912 Brazikumab 2件: 96, 97
69 IL23A 2件: Th17 cell differentiation, Tuberculosis D11052 Risankizumab 4件: 37, 96, 97, 271
70 IL23A 2件: Th17 cell differentiation, Tuberculosis D11123 Mirikizumab 3件: 37, 96, 97
71 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
72 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
73 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
74 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
75 PPP3CA 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 1件: 222
76 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
77 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
78 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
79 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
80 PPP3CB 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 1件: 222
81 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
82 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
83 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
84 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
85 PPP3CC 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 1件: 222
86 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
87 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
88 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
89 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
90 PPP3R1 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 1件: 222
91 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00107 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
92 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D00184 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326
93 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D05480 Pimecrolimus 1件: 160
94 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D08556 Tacrolimus 34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299
95 PPP3R2 4件: Wnt signaling pathway, VEGF signaling pathway, Th17 cell differentiation, Tuberculosis D09033 Voclosporin 1件: 222
96 PRKCQ 2件: Vascular smooth muscle contraction, Th17 cell differentiation D09671 Sotrastaurin 1件: 97
97 MAPK11 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
98 MAPK11 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
99 MAPK13 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
100 MAPK13 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
101 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D00094 Tretinoin 6件: 2, 62, 63, 75, 94, 231
102 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D00348 Isotretinoin 4件: 36, 39, 159, 160
103 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D01418 Tamibarotene 2件: 26, 96
104 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D02754 Acitretin 1件: 37
105 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D02815 Alitretinoin 1件: 49
106 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D04162 Fenretinide 1件: 299
107 RARA 2件: Th17 cell differentiation, Transcriptional misregulation in cancer D06543 Vitamin A 3件: 13, 53, 90
108 RELA 8件: Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis D12181 Edasalonexent 1件: 113
109 RXRA 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin 1件: 37
110 RXRA 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin 1件: 49
111 RXRA 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene 2件: 13, 75
112 RXRB 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin 1件: 37
113 RXRB 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin 1件: 49
114 RXRB 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene 2件: 13, 75
115 RXRG 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02754 Acitretin 1件: 37
116 RXRG 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D02815 Alitretinoin 1件: 49
117 RXRG 4件: Th17 cell differentiation, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Thyroid cancer D03106 Bexarotene 2件: 13, 75
118 MAPK12 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D09639 Losmapimod 2件: 113, 222
119 MAPK12 8件: VEGF signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Thermogenesis, Yersinia infection, Toxoplasmosis, Tuberculosis D10959 Neflamapimod 1件: 8
120 TGFB1 3件: Th17 cell differentiation, Toxoplasmosis, Tuberculosis D09620 Fresolimumab 4件: 51, 85, 222, 274
121 TYK2 2件: Th17 cell differentiation, Toxoplasmosis D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
122 TYK2 2件: Th17 cell differentiation, Toxoplasmosis D11817 Deucravacitinib 2件: 96, 97
123 CD3D 1件: Th17 cell differentiation D05092 Muromonab 3件: 60, 96, 97
124 CD3D 1件: Th17 cell differentiation D06314 Visilizumab 2件: 96, 97
125 CD3D 1件: Th17 cell differentiation D08959 Otelixizumab 1件: 46
126 CD3E 1件: Th17 cell differentiation D05092 Muromonab 3件: 60, 96, 97
127 CD3E 1件: Th17 cell differentiation D06314 Visilizumab 2件: 96, 97
128 CD3E 1件: Th17 cell differentiation D08959 Otelixizumab 1件: 46
129 CD3E 1件: Th17 cell differentiation D11463 Mosunetuzumab 1件: 49
130 CD3G 1件: Th17 cell differentiation D05092 Muromonab 3件: 60, 96, 97
131 CD3G 1件: Th17 cell differentiation D06314 Visilizumab 2件: 96, 97
132 CD3G 1件: Th17 cell differentiation D08959 Otelixizumab 1件: 46